ÐÇ¿Õ´«Ã½

Skip to main content

Wegovy weight loss sustained for four years in trial, Novo Nordisk says

FILE - In this Jan. 20, 2010 file photo, a subject's waist is measured during an obesity prevention study in Chicago. (AP Photo/M. Spencer Green, File) FILE - In this Jan. 20, 2010 file photo, a subject's waist is measured during an obesity prevention study in Chicago. (AP Photo/M. Spencer Green, File)
Share
LONDON -

Patients taking Novo Nordisk's popular Wegovy obesity treatment maintained an average of 10 per cent weight loss after four years on the treatment, the company said on Tuesday.

Novo presented the new long-term data at the European Congress on Obesity in Venice, Italy, gleaned from a large study for which much of the results had been published last year.

"This is the longest study we've conducted so far of semaglutide for weight loss," Martin Holst Lange, Novo's head of development, said in an interview, referring to the active ingredient in Wegovy and the company's diabetes drug Ozempic.

"We see that once the majority of the weight loss is accrued, you don't go back and start to increase in weight if you stay on the drug," he added.

The data could bolster the company's case as it tries to convince insurers and governments to reimburse Wegovy and deflect notions that it is a lifestyle drug.

Wegovy was the first to market from a newer generation of medicines known as GLP-1 agonists, originally developed for diabetes, that provide a new way to address record obesity rates. Eli Lilly launched its rival drug Zepbound in the United States in December. Neither company has been able to produce enough to meet unprecedented demand.

Dr. Simon Cork, Senior Lecturer in Physiology from Anglia Ruskin University, said Britain's public health service's decision to limit coverage of the medicine to two years was "because of questionable long-term effectiveness."

The new data showing benefits continuing to four years may go some way to negating that argument, he said.

The 17,604-patient trial tested Wegovy not for weight loss but for its heart protective benefits for overweight and obese patients who had preexisting heart disease but not diabetes.

Participants were not required to track diet and exercise because it was not an obesity study.

Patients in the trial called Select lost an average of nearly 10 per cent of their total body weight after 65 weeks on Wegovy.

That percentage weight-loss was roughly sustained year-on-year until the end of about four years, where weight loss stood at 10.2 per cent, the company said.

Wegovy and Zepbound are being tested to assess their benefits in a variety of other medical uses such as lowering heart attack risk and for sleep apnea and kidney disease.

The weight loss in the heart trial was less than the average of 15 per cent weight loss in earlier Wegovy obesity studies before the drug was launched in the United States in June 2021. 

CTVNews.ca ÐÇ¿Õ´«Ã½

The eight sons of Richard and Sarah Harvie from Gormanville, N.S., are believed to be the most siblings from one family, from either North America or the British Commonwealth, to serve in World War II.

A 30-year-old northwestern Ontario woman has been charged with arson following a structure fire Thursday night, police say.

One person is dead after the driver of a pickup truck hit a bench where two people were waiting for the bus in Surrey Saturday afternoon, police have confirmed.

opinion

opinion Tips on managing your financial stress

Financial strain can be an uncomfortable burden to bear, especially if you feel that you're doing as much as you can and are barely managing to stay afloat. Personal finance contributor Christopher Liew shares some tips for managing financial stress and digging your way out of debt.

A Toronto police officer has been arrested after allegedly stealing three bottles of alcohol from a store.

Local Spotlight

Chantal Kreviazuk is set to return to Winnipeg to mark a major milestone in her illustrious musical career.

From the beaches of Cannes to the bustling streets of New York City, a new film by a trio of Manitoba directors has toured the international film festival circuit to much pomp and circumstance.

A husband and wife have been on the road trip of a lifetime and have decided to stop in Saskatchewan for the winter.

The grave of a previously unknown Canadian soldier has been identified as a man from Hayfield, Man. who fought in the First World War.

A group of classic car enthusiasts donated hundreds of blankets to nursing homes in Nova Scotia.

Moving into the second week of October, the eastern half of Canada can expect some brisker fall air to break down from the north

What does New Westminster's təməsew̓txʷ Aquatic and Community Centre have in common with a historic 68,000-seat stadium in Beijing, an NFL stadium and the aquatics venue for the Paris Olympics? They've all been named among the world's most beautiful sports venues for 2024.

The last living member of the legendary Vancouver Asahi baseball team, Kaye Kaminishi, died on Saturday, Sept. 28, surrounded by family. He was 102 years old.

New data from Greater Vancouver and the Fraser Valley shows a surge in supply and drop in demand in the region's historically hot real estate market.